|

Orchid Chemicals To Buy US Marketing Firm Karalex Pharma

10 June, 2010

Orchid Chemicals & Pharmaceuticals Ltd, a Chennai-based pharmaceutical company, is acquiring Karalex Pharma LLC, a US-based front-end generic marketing and sales services firm, for an undisclosed sum. 

The deal, which will be closed by the month-end, is an all cash transaction.

The acquisition will help Orchid sell its products directly in the US market. “The acquisition will provide a strong US-based sales capability to Orchid, paving the way for synergistic returns from our upcoming and long term strategic generic pharmaceuticals pipeline. The move also endows Orchid, for the first time, an end-to-end coverage capability of the entire generic pharmaceutical business cycle,” K Raghavendra Rao, Managing Director, Orchid Chemicals, said, in the statement. 

Orchid develops and manufactures products in actives, formulations and nutraceuticals segment. It has manufacturing facilities in Chennai and Aurangabad in India, and also in the US and UK, and exports its products across 75 countries globally. It also has two subsidiaries called Orchid Research Laboratories Ltd in Chennai and Bexel Pharmaceuticals Inc in the US, which are engaged in developing new chemical entities for therapeutic use.

The stocks of the company were traded at Rs 151, up by Rs 6.65‎ or 4.61%‎ at the close of Bombay Stock Exchange today. The net revenue and net profit of the company in FY10 were Rs 120 thousands and Rs 54 thousands, respectively.


Leave Your Comment
Orchid Pharma sells penicillin & penem API biz to Hospira for $200M

Orchid Pharma sells penicillin & penem API biz to Hospira for $200M

Bhawna Gupta 5 years ago
Chennai-based global pharma major Orchid Chemicals & Pharmaceuticals Ltd has...
Hospira To Buy Orchid Chemicals' Injectable Business For $400M

Hospira To Buy Orchid Chemicals’ Injectable Business For $400M

Reuters 8 years ago
US based Hospira Inc said on Tuesday that it would buy Orchid Chemicals ;...
Operation Orchid: When Hostile Takeover Fails To Happen

Operation Orchid: When Hostile Takeover Fails To Happen

Pallavi S 7 years ago
Any Indian investment banker worth his salt will tell you hostile takeovers...
No Comments

Orchid Chemicals To Buy US Marketing Firm Karalex Pharma

Powered by WordPress.com VIP